| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $508K | +2.35K | +97.28% | $215.98 | 4.77K | Aug 30, 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Sale | -$154K | -391 | -8.2% | $394.16 | 4.37K | Aug 30, 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Sale | -$626K | -1.58K | -36.16% | $395.76 | 2.79K | Aug 30, 2023 | Direct | F2 |
| transaction | BIO | Bio-Rad A Common Stock | Sale | -$149K | -377 | -13.5% | $396.44 | 2.42K | Aug 30, 2023 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2.35K | -100% | $0.00 | 0 | Aug 30, 2023 | Bio-Rad A Common Stock | 2.35K | $215.98 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $394.01 to $394.95, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $395.07 to $395.95, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $396.09 to $396.53, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted. |